SCHEMBL19620781

SCHEMBL19620781

CCCC(/C=C(/C)NC=O)=C(/C)CNC(=O)c1cc(Br)cc2c1ccn2CC

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.32
CNR2 P34972 2/20 0.31
CNR1 P21554 1/20 0.31
CYP19A1 P11511 1/20 0.30
METTL3 Q86U44 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620879 0.76 EZH2 (0.35)
SCHEMBL19620960 0.71 EZH2 (0.33)
SCHEMBL19620983 0.69 SMN1; SMN2 (0.35) LMNA
SCHEMBL16115897 0.67 NR4A2 (0.51) LMNACNR1CYP19A1
SCHEMBL19621046 0.67
SCHEMBL16116137 0.61 NR4A2 (0.43) LMNACNR2CNR1
SCHEMBL19620958 0.59 PSMB11 (0.31)
SCHEMBL19620938 0.58 EZH2 (0.33)
SCHEMBL31363868 0.58 NR4A2 (0.41) LMNA
SCHEMBL31363930 0.56 ASH1L (0.37) CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3246027-A1 INDOLE DERIVATIVES FOR THE TREATMENT OF CANCER GlaxoSmithKline LLC (US) 2017-11-22 EP disclosed